Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003318180 | SCV004021672 | pathogenic | not provided | 2023-07-19 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29595516, 22309630, 19728179, 21822006) |
Labcorp Genetics |
RCV003318180 | SCV004295708 | pathogenic | not provided | 2023-12-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys110*) in the CYP17A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP17A1 are known to be pathogenic (PMID: 10720067, 14747197, 17192295, 20197673, 24140098). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with CYP17A1-related conditions (PMID: 21822006). ClinVar contains an entry for this variant (Variation ID: 2573844). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV004572922 | SCV005059311 | pathogenic | Deficiency of steroid 17-alpha-monooxygenase | 2023-11-20 | criteria provided, single submitter | clinical testing |